Skip to main content
Advertisement
Advertisement
IXHL
IXHL logo
Incannex Healthcare Limited Common Stock
2.24
USD
Sponsored
-0.03
-1.32%
Nov 06, 15:59 UTC -5
Closed
exchange

After-Market

2.29

+0.04
+2.01%

Incannex Healthcare Limited Common Stock (IXHL) Profile

Incannex Healthcare Limited Common Stock Profile

About

Incannex Healthcare Limited is a clinical-stage pharmaceutical company developing unique medicinal cannabis pharmaceutical products and psychedelic medicine therapies for unmet medical needs. Incannex Healthcare Limited is based in MELBOURNE, Australia.

Info & Links

CEO

Joel Latham

Headquarters

525 Collins Street
Melbourne, VIC 3008, AUSTRALIA

Sector

Medical

Auditor

GRANT THORNTON AUDIT PTY LTD

Share holders

4,560

Employees

12

Incannex Healthcare Limited Common Stock Statistics

Valuation Measures

Market Capitalization2

28.66M

Enterprise Value

-39.05M

Enterprise Value/EBITDA(ttm)

1.71

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

0.42

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

-25.62%

Return on Invested Capital(ttm)

-26.06%

Return on Assets(ttm)

-24.46%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-22.79M

Net Income Available to Common(ttm)

-19.30M

Diluted EPS(ttm)

-1.69

Share Statistics

Beta (5Y Monthly)

7.00

52-Week Change

-79.49%

S&P 500 52-Week Change

14.03%

S&P 500 Member

No

Stock Optionable

Yes

Total Shares Outstanding1

12.54M

Dividend Yield

0.00%

Float4

12.38M

% Held by Insiders

1.33%

% Held by Institutions

0.43%

Balance Sheet

Total Cash(mrq)

67.71M

Total Cash Per Share(mrq)

5.40

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

48.81%

Quick Ratio(mrq)

48.81%

Book Value Per Share(mrq)

5.37

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.10

Free Cash Flow(ytd)

-12.88M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement